Target intelligence / Profile preview

FLJ38576 RNA gene (FLJ38576)

Target
FLJ38576
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

FLJ38576 RNA gene (uncharacterized LOC651430) is a human long non-coding RNA (lncRNA) gene, for which there is insufficient information regarding structure, molecular function, biological processes, or therapeutic targeting. It is listed in genetic databases and has been noted for a tentative disease association with Angelman Syndrome, but its role, molecular pathway involvement, and druggability are currently unknown[4].

Other names
FLJ38576uncharacterized LOC651430LOC651430
02

Disease associations

Angelman Syndrome

Beyond the preview

Go deeper on FLJ38576 RNA gene (FLJ38576).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FLJ38576 RNA gene (FLJ38576).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call